Kircik, C., & Kircik, L. (2023). Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study. Journal of drugs in dermatology, 22(3), 271. https://doi.org/10.36849/JDD.7165
Chicago Style (17th ed.) CitationKircik, Charles, and Leon Kircik. "Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study." Journal of Drugs in Dermatology 22, no. 3 (2023): 271. https://doi.org/10.36849/JDD.7165.
MLA (9th ed.) CitationKircik, Charles, and Leon Kircik. "Patient Preference for Calcipotriene and Betamethasone Dipropionate Cream Versus Foam for the Topical Treatment of Psoriasis: A Pilot Study." Journal of Drugs in Dermatology, vol. 22, no. 3, 2023, p. 271, https://doi.org/10.36849/JDD.7165.